{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:16:36Z","timestamp":1791396996861,"version":"4.3.3"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":210,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Synapse"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1002\/syn.21805","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T12:06:48Z","timestamp":1421928408000},"page":"183-189","source":"Crossref","is-referenced-by-count":151,"title":["Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors"],"prefix":"10.1002","volume":"69","author":[{"given":"Philip","family":"Seeman","sequence":"first","affiliation":[{"name":"Departments of Pharmacology and Psychiatry; Faculty of Medicine, University of Toronto; 260 Heath Street West, Unit 605, Toronto Ontario M5P 3L6 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"issue":"Suppl","key":"10.1002\/syn.21805-BIB0001|syn21805-cit-0001","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.parkreldis.2007.06.002","article-title":"Continuous dopaminergic stimulation-From theory to clinical practice","volume":"13","author":"Antonini","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1002\/syn.21805-BIB0002|syn21805-cit-0002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.parkreldis.2011.06.001","article-title":"Impulse control disorders in Chinese Parkinson's disease patients: The effect of ergot derived dopamine agonist","volume":"17","author":"Auyeung","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1002\/syn.21805-BIB0003|syn21805-cit-0003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson's disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Mov Disord"},{"key":"10.1002\/syn.21805-BIB0004|syn21805-cit-0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.870090204","article-title":"N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease","volume":"9","author":"Belluzzi","year":"1994","journal-title":"Mov Disord"},{"key":"10.1002\/syn.21805-BIB0005|syn21805-cit-0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0317167100010489","article-title":"Outcomes of patients with Parkinson disease and pathological gambling","volume":"37","author":"Bharmal","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1002\/syn.21805-BIB0006|syn21805-cit-0006","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/add.12066","article-title":"The D2\/3 dopamine receptor in pathological gambling: A positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride","volume":"108","author":"Boileau","year":"2013a","journal-title":"Addiction"},{"key":"10.1002\/syn.21805-BIB0007|syn21805-cit-0007","article-title":"In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO","author":"Boileau","year":"2013b","journal-title":"Mol Psychiatry"},{"key":"10.1002\/syn.21805-BIB0008|syn21805-cit-0008","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0025-6196(11)60538-7","article-title":"Frequency of new-onset pathologic compulsive gambling or hypersexuality after treatment of idiopathic Parkinson disease","volume":"84","author":"Bostwick","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1002\/syn.21805-BIB0009|syn21805-cit-0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","article-title":"The neurobiology and genetics of impulse control disorders: relationships to drug addictions","volume":"75","author":"Brewer","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/syn.21805-BIB0010|syn21805-cit-0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1002\/syn.21805-BIB0011|syn21805-cit-0011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3565(25)38490-9","article-title":"Expression and pharmacological characterization of the human D3 dopamine receptor","volume":"268","author":"Freedman","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/syn.21805-BIB0012|syn21805-cit-0012","article-title":"Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: A multicentre study","volume":"2014","author":"Garcia-Ruiz","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/syn.21805-BIB0013|syn21805-cit-0013","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1210\/endo-117-2-690","article-title":"The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form","volume":"117","author":"George","year":"1985","journal-title":"Endocrinology"},{"key":"10.1002\/syn.21805-BIB0014|syn21805-cit-0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s002130050131","article-title":"Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907","volume":"128","author":"Hall","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1002\/syn.21805-BIB0015|syn21805-cit-0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","article-title":"Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies","volume":"17","author":"Hassan","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1002\/syn.21805-BIB0016|syn21805-cit-0016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.parkreldis.2011.09.007","article-title":"Impulse control disorders and depression in Finnish patients with Parkinson's disease","volume":"18","author":"Joutsa","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1002\/syn.21805-BIB0017|syn21805-cit-0017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0893-133X(96)00276-X","article-title":"Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia","volume":"16","author":"Joyce","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/syn.21805-BIB0018|syn21805-cit-0018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(95)00069-W","article-title":"Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities","volume":"277","author":"Kreiss","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/syn.21805-BIB0019|syn21805-cit-0019","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3389\/fpsyg.2013.00709","article-title":"The Iowa Gambling Task and the three fallacies of dopamine in gambling disorder","volume":"4","author":"Linnet","year":"2013","journal-title":"Front Psychol"},{"key":"10.1002\/syn.21805-BIB0020|syn21805-cit-0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","article-title":"Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas","volume":"34","author":"Martinkova","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1002\/syn.21805-BIB0021|syn21805-cit-0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0303-7207(84)90037-6","article-title":"Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors","volume":"36","author":"McDonald","year":"1984","journal-title":"Mol Cell Endocrinol"},{"key":"10.1002\/syn.21805-BIB0022|syn21805-cit-0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0922-4106(95)90013-6","article-title":"Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors","volume":"290","author":"Mierau","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/syn.21805-BIB0023|syn21805-cit-0023","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/syn.21805-BIB0024|syn21805-cit-0024","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"10.1002\/syn.21805-BIB0025|syn21805-cit-0025","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intl Med"},{"key":"10.1002\/syn.21805-BIB0026|syn21805-cit-0026","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","article-title":"Predictors of impulsivity and reward seeking behavior with dopamine agonists","volume":"14","author":"Ondo","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1002\/syn.21805-BIB0027|syn21805-cit-0027","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0014-2999(98)00896-6","article-title":"Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors","volume":"366","author":"Perachon","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/syn.21805-BIB0028|syn21805-cit-0028","first-page":"141","article-title":"Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease","volume":"21","author":"Piercey","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1002\/syn.21805-BIB0029|syn21805-cit-0029","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0b013e3182979830","article-title":"A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: Association with dopaminergic drugs","volume":"33","author":"Poletti","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/syn.21805-BIB0030|syn21805-cit-0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00210-008-0341-4","article-title":"The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease","volume":"379","author":"Scheller","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/syn.21805-BIB0031|syn21805-cit-0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(92)90196-B","article-title":"Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo","volume":"218","author":"Schotte","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/syn.21805-BIB0032|syn21805-cit-0032","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/syn.20453","article-title":"Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors","volume":"61","author":"Seeman","year":"2007","journal-title":"Synapse"},{"key":"10.1002\/syn.21805-BIB0033|syn21805-cit-0033","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1755-5949.2010.00162.x","article-title":"All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2High receptors","volume":"17","author":"Seeman","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1002\/syn.21805-BIB0034|syn21805-cit-0034","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0922-4106(95)90125-6","article-title":"Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand","volume":"291","author":"Seeman","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/syn.21805-BIB0035|syn21805-cit-0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/syn.20193","article-title":"Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors","volume":"58","author":"Seeman","year":"2005","journal-title":"Synapse"},{"key":"10.1002\/syn.21805-BIB0036|syn21805-cit-0036","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/syn.20298","article-title":"Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1002\/syn.21805-BIB0037|syn21805-cit-0037","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2high dopamine receptors","volume":"60","author":"Seeman","year":"2006a","journal-title":"Synapse"},{"key":"10.1002\/syn.21805-BIB0038|syn21805-cit-0038","first-page":"224","article-title":"Localization and function of the D3 dopamine receptor","volume":"42","author":"Sokoloff","year":"1992a","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/syn.21805-BIB0039|syn21805-cit-0039","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0922-4106(92)90107-7","article-title":"Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: Comparison with D2 receptor","volume":"225","author":"Sokoloff","year":"1992b","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/syn.21805-BIB0040|syn21805-cit-0040","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1530-0277.1996.tb05936.x","article-title":"Decreases in dopamine receptors but not in dopamine transporters in alcoholics","volume":"20","author":"Volkow","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1002\/syn.21805-BIB0041|syn21805-cit-0041","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviors in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1002\/syn.21805-BIB0042|syn21805-cit-0042","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1002\/syn.21805-BIB0043|syn21805-cit-0043","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1002\/syn.21805-BIB0044|syn21805-cit-0044","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hbm.21067","article-title":"Pramipexole modulates the neural network of reward anticipation","volume":"32","author":"Ye","year":"2011","journal-title":"Hum Brain Mapp"}],"container-title":["Synapse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsyn.21805","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/syn.21805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T12:50:03Z","timestamp":1747486203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/syn.21805"}},"subtitle":["Impulse-Control Disorder and D3 Receptors"],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1002\/syn.21805","relation":{},"ISSN":["0887-4476"],"issn-type":[{"value":"0887-4476","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}